The relationship between TP53 mutations and p53 IHC patterns is well‐studied in ovarian carcinoma, endometrial carcinoma, and vulvar squamous cell carcinoma but remains unclear in breast cancer.10, 11, 12, 13, 14. This evidence concerns the gene TP53 and breast cancer.